In last trading session, ReShape Lifesciences Inc (NASDAQ:RSLS) saw 0.44 million shares changing hands with its beta currently measuring 1.21. Company’s recent per share price level of $2.44 trading at $0.06 or 2.52% at ring of the bell on the day assigns it a market valuation of $5.82M. That closing price of RSLS’s stock is at a discount of -16907.79% from its 52-week high price of $414.99 and is indicating a premium of 8.61% from its 52-week low price of $2.23. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.65 million shares which gives us an average trading volume of 3.05 million if we extend that period to 3-months.
For ReShape Lifesciences Inc (RSLS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
ReShape Lifesciences Inc (NASDAQ:RSLS) trade information
Upright in the green during last session for gaining 2.52%, in the last five days RSLS remained trading in the red while hitting it’s week-highest on Wednesday, 06/25/25 when the stock touched $2.44 price level, adding 19.47% to its value on the day. ReShape Lifesciences Inc’s shares saw a change of -99.16% in year-to-date performance and have moved -4.31% in past 5-day. ReShape Lifesciences Inc (NASDAQ:RSLS) showed a performance of -46.72% in past 30-days. Number of shares sold short was 0.95 million shares which calculate 0.15 days to cover the short interests.
ReShape Lifesciences Inc (RSLS) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 80.05% during past 5 years.
ReShape Lifesciences Inc (NASDAQ:RSLS)’s Major holders
Insiders are in possession of 10.63% of company’s total shares while institution are holding 0.73 percent of that, with stock having share float percentage of 0.81%. Investors also watch the number of corporate investors in a company very closely, which is 0.73% institutions for ReShape Lifesciences Inc that are currently holding shares of the company.
On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Apr 30, 2025 , the former fund manager was holding 373.0 shares of worth $910.0 or 0.03% of the total outstanding shares. The later fund manager was in possession of 34.0 shares on Mar 31, 2025 , making its stake of worth around $82.0 in the company or a holder of 0.00% of company’s stock.
